Washington hospital to receive first PET radioisotopes from AMIC
Advanced Medical Isotope Corporation (AMIC) has made its initial delivery of short-lived radioisotopes to be used in PET from the Kennewick, Wash.-based production center to Kadlec Medical Center of Richland, Wash.
“AMIC is delighted to assist our region's healthcare needs and be a local source for the production of a multitude of radioisotopes,” President William J. Stokes said.
Utilizing a PET machine, the company said that a patient is given a small amount of a radioactive pharmaceutical, such as fluorodeoxyglucose (FDG), and results are then generally interpreted by a radiologist or by a nuclear medicine physician to configure the patient's diagnosis and treatment plan.
AMIC said that FDG can be utilized for a variety of purposes, including diagnosis and monitoring the treatment of Hodgkin's disease, non-Hodgkin's lymphoma, Alzheimer's disease and lung cancer.
Kadlec Medical Center is a regional referral center, serving southeast Washington and northeast Oregon.
“AMIC is delighted to assist our region's healthcare needs and be a local source for the production of a multitude of radioisotopes,” President William J. Stokes said.
Utilizing a PET machine, the company said that a patient is given a small amount of a radioactive pharmaceutical, such as fluorodeoxyglucose (FDG), and results are then generally interpreted by a radiologist or by a nuclear medicine physician to configure the patient's diagnosis and treatment plan.
AMIC said that FDG can be utilized for a variety of purposes, including diagnosis and monitoring the treatment of Hodgkin's disease, non-Hodgkin's lymphoma, Alzheimer's disease and lung cancer.
Kadlec Medical Center is a regional referral center, serving southeast Washington and northeast Oregon.